Healthcare provider profile · identity verified

David L Barrasso, M.D.

Internal Medicine · MEDFORD, MA · NPI 1467433748

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	946	68
Eliquis	Apixaban	811	43
Levothyroxine Sodium	Levothyroxine Sodium	631	45
Gabapentin	Gabapentin	596	40
Trazodone Hcl	Trazodone Hcl	533	49
Metoprolol Succinate	Metoprolol Succinate	532	40
Furosemide	Furosemide	509	48
Mirtazapine	Mirtazapine	498	44
Amlodipine Besylate	Amlodipine Besylate	423	36
Quetiapine Fumarate	Quetiapine Fumarate	366	27
Pantoprazole Sodium	Pantoprazole Sodium	334	22
Lisinopril	Lisinopril	324	22
Sertraline Hcl	Sertraline Hcl	308	30
Levetiracetam	Levetiracetam	290	18
Metoprolol Tartrate	Metoprolol Tartrate	264	26
Omeprazole	Omeprazole	245	14
Metformin Hcl	Metformin Hcl	239	20
Divalproex Sodium	Divalproex Sodium	229	19
Risperidone	Risperidone	213	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	212	22
Potassium Chloride	Potassium Chloride	203	21
Escitalopram Oxalate	Escitalopram Oxalate	193	14
Fluoxetine Hcl	Fluoxetine Hcl	165	suppressed
Pravastatin Sodium	Pravastatin Sodium	150	suppressed
Donepezil Hcl	Donepezil Hcl	143	16
Duloxetine Hcl	Duloxetine Hcl	140	14
Baclofen	Baclofen	137	suppressed
Simvastatin	Simvastatin	135	13
Famotidine	Famotidine	134	15
Losartan Potassium	Losartan Potassium	127	13
Memantine Hcl	Memantine Hcl	122	11
Citalopram Hbr	Citalopram Hydrobromide	121	16
Buspirone Hcl	Buspirone Hcl	120	11
Olanzapine	Olanzapine	108	suppressed
Xarelto	Rivaroxaban	108	suppressed
Aripiprazole	Aripiprazole	102	suppressed
Allopurinol	Allopurinol	96	suppressed
Propranolol Hcl	Propranolol Hcl	91	suppressed
Spironolactone	Spironolactone	87	suppressed
Ropinirole Hcl	Ropinirole Hcl	83	suppressed
Divalproex Sodium Er	Divalproex Sodium	82	suppressed
Torsemide	Torsemide	81	suppressed
Carvedilol	Carvedilol	78	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	77	suppressed
Clopidogrel	Clopidogrel Bisulfate	76	suppressed
Cephalexin	Cephalexin	71	13
Latanoprost	Latanoprost	69	11
Januvia	Sitagliptin Phosphate	68	suppressed
Perphenazine	Perphenazine	68	suppressed
Amiodarone Hcl	Amiodarone Hcl	67	suppressed
Metformin Hcl Er	Metformin Hcl	62	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	60	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	59	suppressed
Glipizide	Glipizide	57	suppressed
Jardiance	Empagliflozin	57	suppressed
Methenamine Hippurate	Methenamine Hippurate	57	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	56	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	55	suppressed
Rytary	Carbidopa/Levodopa	55	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	54	suppressed
Warfarin Sodium	Warfarin Sodium	52	suppressed
Atenolol	Atenolol	50	suppressed
Sucralfate	Sucralfate	50	suppressed
Ezetimibe	Ezetimibe	47	suppressed
Montelukast Sodium	Montelukast Sodium	47	suppressed
Myrbetriq	Mirabegron	47	suppressed
Paroxetine Hcl	Paroxetine Hcl	45	suppressed
Primidone	Primidone	45	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	44	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	43	suppressed
Prednisone	Prednisone	42	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	41	17
Zonisamide	Zonisamide	41	suppressed
Finasteride	Finasteride	40	suppressed
Folic Acid	Folic Acid	40	suppressed
Prazosin Hcl	Prazosin Hcl	39	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	38	suppressed
Verapamil Er	Verapamil Hcl	38	suppressed
Alendronate Sodium	Alendronate Sodium	37	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Desipramine Hcl	Desipramine Hcl	34	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	31	suppressed
Carbamazepine	Carbamazepine	30	suppressed
Labetalol Hcl	Labetalol Hcl	30	suppressed
Olanzapine Odt	Olanzapine	30	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	29	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	28	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Fondaparinux Sodium	Fondaparinux Sodium	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Lactulose	Lactulose	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Ketoconazole	Ketoconazole	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Trintellix	Vortioxetine Hydrobromide	24	suppressed
Xifaxan	Rifaximin	24	suppressed
Acetazolamide	Acetazolamide	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	22	20
Phenytoin	Phenytoin	22	suppressed
Rexulti	Brexpiprazole	22	suppressed
Nystatin	Nystatin	21	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	21	suppressed
Topiramate	Topiramate	21	suppressed
Valproic Acid	Valproic Acid	21	suppressed
Anastrozole	Anastrozole	20	suppressed
Captopril	Captopril	20	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	20	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	20	suppressed
Haloperidol	Haloperidol	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Levofloxacin	Levofloxacin	19	15
Midodrine Hcl	Midodrine Hcl	19	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	17
Neupro	Rotigotine	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Ursodiol	Ursodiol	17	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	16	suppressed
Alosetron Hcl	Alosetron Hcl	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	16	suppressed
Oxcarbazepine	Oxcarbazepine	15	suppressed
Prednisolone Acetate	Prednisolone Acetate	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Verapamil Hcl	Verapamil Hcl	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Colchicine	Colchicine	12	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Exemestane	Exemestane	12	suppressed
Metformin Er Osmotic	Metformin Hcl	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Nitroglycerin Patch	Nitroglycerin	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Nystop	Nystatin	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error